FUTAPAN 40 MG 28TAB

FUTAPAN 40 MG 28TAB

Description:

FUTAPAN 40 mg 28 enteric-coated tablets is a prescription medicine containing pantoprazole, a proton pump inhibitor (PPI) used to reduce excess stomach acid. It is commonly prescribed for gastric and duodenal ulcers, gastroesophageal reflux disease (GERD), and conditions associated with pathological hypersecretion of acid such as Zollinger–Ellison syndrome. By selectively inhibiting the gastric proton pump in the stomach’s parietal cells, FUTAPAN 40 mg provides effective and long-lasting relief from heartburn, acid reflux, and related symptoms, and supports healing of acid-related damage in the esophagus and stomach.

Indications:

• Treatment of gastroesophageal reflux disease (GERD), including erosive esophagitis caused by acid reflux.
• Short- and long-term treatment of gastric and duodenal ulcers.
• Relief of symptoms associated with hyperacidity such as heartburn, acid regurgitation, and epigastric pain.
• Management of pathological hypersecretory conditions, including Zollinger–Ellison syndrome and other conditions with excessive gastric acid production.
• Prevention of relapse of GERD and peptic ulcers in patients requiring maintenance therapy, as directed by a physician.
• Prevention of NSAID-associated gastric and duodenal ulcers in at-risk patients, when prescribed by a healthcare professional.

Active Ingredients / Key Components:

• Pantoprazole sodium (equivalent to pantoprazole) – 40 mg per enteric-coated tablet.
• Other excipients: The full list of inactive ingredients (excipients, coating agents, stabilizers, preservatives) is not available in the provided information. Please refer to the official package insert for complete details.

Dosage & Administration / How to Use:

• Adults with GERD / reflux symptoms: The usual dose is 40 mg (1 tablet) once daily, swallowed whole with water. Do not crush, chew, or split the tablet, as it is enteric-coated.
• Gastric and duodenal ulcers: Commonly 40 mg once daily; in some cases, your doctor may increase to 40 mg twice daily for severe or resistant cases.
• Zollinger–Ellison syndrome and other hypersecretory conditions: Initial dose often 40 mg twice daily, then adjusted individually by the physician based on acid output and clinical response.
• Administration: Take preferably before a meal (usually in the morning). If prescribed twice daily, take the second dose before the evening meal or as directed by your doctor.
• Duration of treatment: Typically 2–4 weeks for duodenal ulcers and up to 4–8 weeks for gastric ulcers and erosive esophagitis. Long-term therapy may be required for chronic conditions, strictly under medical supervision.
• Missed dose: If you miss a dose, take it as soon as you remember unless it is almost time for your next dose. Do not double the dose to make up for a missed tablet.
• Use in children: Dosage and use in pediatric patients must be determined by a pediatrician; do not administer to children without medical advice.
• Always follow your doctor’s instructions and the dosing schedule on the prescription label. Do not change the dose or stop treatment abruptly without consulting your healthcare provider.

Clinical Benefits:

• Effectively reduces gastric acid secretion by irreversibly inhibiting the H+ / K+ ATPase (proton pump) in gastric parietal cells.
• Provides sustained relief from heartburn, acid reflux, and epigastric pain, improving daily comfort and quality of life.
• Promotes healing of gastric and duodenal ulcers and erosive esophagitis by maintaining a less acidic environment in the stomach.
• Helps prevent recurrence of GERD symptoms and peptic ulcers when used as maintenance therapy under medical supervision.
• Useful in managing pathological hypersecretory conditions (such as Zollinger–Ellison syndrome) by controlling excessive acid production.

Warnings & Contraindications:

• Contraindicated in patients with known hypersensitivity to pantoprazole, other proton pump inhibitors, or any component of the formulation.
• Do not use for mild, occasional indigestion without medical evaluation; persistent symptoms may indicate a more serious condition (e.g., gastric cancer) that requires diagnosis.
• Seek immediate medical attention if you experience alarm symptoms such as unexplained weight loss, repeated vomiting, difficulty swallowing, vomiting blood, or black/tarry stools.
• Long-term use of PPIs may be associated with increased risk of vitamin B12 deficiency, magnesium deficiency, bone fractures (especially in the elderly or those on high doses), and certain infections (e.g., Clostridioides difficile-associated diarrhea). Use the lowest effective dose for the shortest duration necessary.
• Use with caution in patients with severe liver impairment; dose adjustment or monitoring may be required. Inform your doctor if you have liver disease.
• May interact with certain medications (e.g., warfarin, methotrexate, atazanavir, ketoconazole, erlotinib, and others). Inform your doctor and pharmacist about all medicines and supplements you are taking.
• Consult your doctor before use if pregnant or breastfeeding. Pantoprazole should be used during pregnancy or lactation only if clearly needed and prescribed by a physician.
• Not intended to diagnose, treat, cure, or prevent any disease without proper medical supervision.
• Keep out of reach of children. Accidental ingestion in children requires immediate medical attention.

Side Effects:

• Common side effects: Headache, dizziness, abdominal pain, diarrhea, constipation, flatulence, nausea, or vomiting. These are usually mild and transient.
• Less common side effects: Rash, itching, sleep disturbances, joint pain, or muscle pain.
• Rare but serious side effects: Severe allergic reactions (swelling of face, lips, tongue, or throat; difficulty breathing), severe skin reactions, jaundice or signs of liver problems (yellowing of skin or eyes, dark urine), severe or persistent diarrhea, or signs of low magnesium (muscle cramps, irregular heartbeat, seizures).
• Stop taking the medicine and seek immediate medical attention if you experience symptoms of a serious allergic reaction or any severe or unusual symptoms.
• Report persistent or bothersome side effects to your doctor or pharmacist.

Storage Instructions:

Store in a cool, dry place away from direct sunlight and moisture. Keep the blister pack in the outer carton to protect from light. Do not store above the temperature recommended on the package (typically below 25–30°c, refer to pack). Keep container tightly closed and out of reach of children. Do not use after the expiry date printed on the pack.

Specifications:

• Active ingredient: pantoprazole 40 mg per enteric-coated tablet.
• Form: enteric-coated tablets (e.c. tabs) for oral use.
• Pack size: 28 tablets per pack.
• Intended use: prescription medicine for reduction of gastric acid and treatment of acid-related disorders.

Disclaimer:
All pharmacy products are intended for general use only and do not replace professional medical advice, diagnosis, or treatment. Always consult a healthcare provider before use. Results may vary, and no specific outcomes are guaranteed. Products are not intended to diagnose, treat, cure, or prevent any disease unless stated. Follow label instructions carefully, as misuse may cause adverse effects. Compliance with local laws is the customer’s responsibility.